Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes: A prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)

OBJECTIVE—In patients with type 2 diabetes, left ventricular hypertrophy (LVH) predicts cardiovascular events, and the prevention of LVH is cardioprotective. We sought to compare the effect of ACE versus non-ACE inhibitor therapy on incident electrocardiographic (ECG) evidence of LVH (ECG-LVH). RESE...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruggenenti, Piero, Iliev, Ilian, Costa, Grazia Maria, Parvanova, Aneliya, Perna, Annalisa, Giuliano, Giovanni Antonio, Motterlini, Nicola, Ene-Iordache, Bogdan, Remuzzi, Giuseppe
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2008
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494629/
https://www.ncbi.nlm.nih.gov/pubmed/18443191
http://dx.doi.org/10.2337/dc08-0371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494629/
https://www.ncbi.nlm.nih.gov/pubmed/18443191
http://dx.doi.org/10.2337/dc08-0371

Ejemplares similares